Rare diseases
Investigational molecules
Locations
Back to Germany262 clinical trials in Bochum, Germany across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
GermanyStudy on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
GermanyStudy on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy
GermanyStudy of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older
GermanyStudy on the Effects of TAK-341 for Patients with Multiple System Atrophy
GermanyStudy Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients
GermanyStudy on the Safety and Effects of Fasudil Hydrochloride for Patients with Parkinson's Disease
GermanyStudy on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma
GermanyStudy on Epirubicin and Sodium Chloride for Patients with Sepsis or Septic Shock in Intensive Care Units
GermanyGermanyStudy Comparing FOLFOX Before Surgery to Risk-Adapted Chemotherapy After Surgery for Patients with Locally Advanced Rectal Cancer and Low Risk of Local Failure
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on skin conditions, including studies for cutaneous lupus erythematosus, hidradenitis suppurativa, and plaque psoriasis. Novel therapeutic approaches are being evaluated to improve treatment outcomes for patients with chronic skin disorders.
Multiple studies are investigating new medications for moderate to severe cases of these conditions.
Innovative research in cancer treatment, particularly focusing on colorectal cancer, pancreatic cancer, gastric cancer, and non-small cell lung cancer. These trials are evaluating targeted therapies and combination treatments.
New therapeutic approaches combining immunotherapy with targeted treatments are being studied.
Studies focusing on heart failure prevention and chronic kidney disease management. Research includes innovative combination therapies and preventive approaches for high-risk patients.
Trials are evaluating new treatment combinations to improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
